CRISPR Cas9 Beta Cell Regeneration Therapy for Type 1 Diabetes: Mechanistic Insights and Clinical Translation
Type 1 diabetes is a chronic autoimmune disorder characterized by immune-mediated destruction of pancreatic beta cells, resulting in lifelong dependence on exogenous insulin and risk of severe metabolic complications. Despite advances in insulin formulations and glucose monitoring technologies, current therapies failed...